前路椎体拴系术治疗特发性脊柱侧凸的前瞻性随访:FDA IDE研究中期结果
本研究为FDA IDE研究的前瞻性随访报告,纳入57例骨骼未成熟的特发性脊柱侧凸患者(Lenke 1A或1B型,Cobb角30°-65°),行前路椎体拴系术(aVBT)。结论认为aVBT安全有效,但翻修率有待改善。
要点
- 平均随访55.2个月,无重大神经或肺部并发症。
- 7例(12.3%)翻修,5例因过度矫正,2例因附加现象。
核心结论
- 前路椎体拴系术是骨骼未成熟特发性脊柱侧凸有前景的治疗选择,研究结果支持其安全性和有效性。
- 翻修率仍需改善,尤其是过度矫正和附加现象导致的翻修。
研究设计与样本
- 前瞻性随访回顾性数据集,单中心,2011年8月至2015年7月纳入57例患者(49女8男),平均年龄12.4±1.3岁。
- 纳入标准为骨骼未成熟、Lenke 1A或1B型曲线、Cobb角30°至65°。
- 影像学参数由独立评审员测量,平均随访55.2±12.5个月。
主要发现
- 主胸段Cobb角术前平均40.4°±6.8°,末次随访矫正至18.7°±13.4°。
- 矢状面T5-T12后凸术前15.5°±10.0°,术后17.0°±10.1°,末次随访19.6°±12.7°。
- 无重大神经或肺部并发症,7例(12.3%)翻修(5例过度矫正,2例附加现象)。
关键数值与推荐
- 纳入标准:骨骼未成熟、Lenke 1A或1B型、Cobb角30°至65°。
- 平均拴系7.5±0.6个节段,手术时间223±79分钟,估计出血量106±86 mL。
- 末次随访平均Risser分级4.2±0.9。
临床怎么用
- aVBT可作为骨骼未成熟特发性脊柱侧凸患者的治疗选项,需注意过度矫正和附加现象导致的翻修风险。
- 术后需长期随访以监测矫正效果和翻修需求。
局限性
- 证据等级为治疗性IV级。
- 单中心研究,样本量57例。
- 为前瞻性随访回顾性数据集,非随机对照研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anterior vertebral body tethering (aVBT) has emerged as a novel treatment option for patients with idiopathic scoliosis. We present the results from the first U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study on aVBT. METHODS: In this prospective review of a retrospective data set, eligible patients underwent aVBT at a single center from August 2011 to July 2015. Inclusion criteria included skeletally immature patients with Lenke type-1A or 1B curves between 30° and 65°. Clinical and radiographic parameters were collected, with the latter measured by an independent reviewer. RESULTS: Fifty-seven patients (49 girls and 8 boys), with a mean age (and standard deviation) of 12.4 ± 1.3 years (range, 10.1 to 15.0 years), were enrolled in the study. The patients had a mean of 7.5 ± 0.6 levels tethered, the mean operative time was 223 ± 79 minutes, and the mean estimated blood loss was 106 ± 86 mL. The patients were followed for an average of 55.2 ± 12.5 months and had a mean Risser grade of 4.2 ± 0.9 at the time of the latest follow-up. The main thoracic Cobb angle was a mean of 40.4° ± 6.8° preoperatively and was corrected to 18.7° ± 13.4° at the most recent follow-up. In the sagittal plane, T5-T12 kyphosis measured 15.5° ± 10.0° preoperatively, 17.0° ± 10.1° postoperatively, and 19.6° ± 12.7° at the most recent follow-up. Eighty percent of patients had curves of <30° at the most recent follow-up. The most recent Scoliosis Research Society (SRS) scores averaged 4.5 ± 0.4, and scores on the self-image questionnaire averaged 4.4 ± 0.7. No major neurologic or pulmonary complications occurred. Seven (12.3%) of 57 patients had a revision: 5 were done for overcorrection and 2, for adding-on. CONCLUSIONS: Anterior VBT is a promising technique that has emerged as a treatment option for patients with immature idiopathic scoliosis. We present the results from the first FDA-approved IDE study on aVBT, which formed the basis for the eventual Humanitarian Device Exemption approval. The findings affirm the safety and efficacy of this technique and suggest opportunities for improvement, particularly with respect to reoperation rates. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Samdani AF, Pahys JM, Ames RJ, et al. Prospective Follow-up Report on Anterior Vertebral Body Tethering for Idiopathic Scoliosis: Interim Results from an FDA IDE Study. J Bone Joint Surg Am. 2021. PMID: 34185722. doi:10.2106/JBJS.20.01503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。